Eli Lilly

    LLY ·NYSE ·Pharmaceutical Preparations ·Inc. in IN
    Loading chart...
    Track markets on TradingView

    Loading financial statements...

    Financial statements

    data from SEC XBRL filings. Values are as-reported; restatements supersede originals.

    showing loading…

    Loading holders...

    Held by

    holders ( registered funds via N-PORT, institutional investors via 13F). Showing top by dollar value.

    Holder Type ETF MF Position ($) % of holder Δ % of holder Holder AUM

    Next expected filings

    • ~2026-05-02 10-Q expected by 2026-06-08 (in 5 days)
    • ~2026-08-08 10-Q expected by 2026-09-14 (in 103 days)
    • ~2026-10-31 10-Q expected by 2026-12-07 (in 187 days)
    • ~2027-02-11 10-K expected by 2027-04-07 (in 290 days)

    Predicted from historical filing cadence; not an SEC commitment.

    Recent SEC filings

    • 2026-02-12 10-K Annual Report
    • 2026-02-04 8-K Earnings Release; Financial Statements and Exhibits
    • 2025-11-21 8-K Officer/Director Change
    • 2025-10-30 10-Q Quarterly Report
    • 2025-10-30 8-K Earnings Release; Financial Statements and Exhibits
    • 2025-08-20 8-K Other Events; Financial Statements and Exhibits
    • 2025-08-07 10-Q Quarterly Report
    • 2025-08-07 8-K Earnings Release; Financial Statements and Exhibits
    • 2025-05-01 10-Q Quarterly Report
    • 2025-05-01 8-K Earnings Release; Financial Statements and Exhibits
    • 2025-02-19 10-K Annual Report
    • 2025-02-12 8-K Other Events; Financial Statements and Exhibits
    • 2025-02-06 8-K Earnings Release; Financial Statements and Exhibits
    • 2025-01-14 8-K Earnings Release; Financial Statements and Exhibits
    • 2024-11-19 8-K Officer/Director Change; Financial Statements and Exhibits